Analysis of viral counter regulation against host's defense mechanism for viral infection using HCV transgenic mouse model
利用HCV转基因小鼠模型分析病毒对宿主病毒感染防御机制的反调节
基本信息
- 批准号:09470088
- 负责人:
- 金额:$ 6.66万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Missing of proper culture system and animal model has hampered fine analysis of viral life cycle and pathogenesis of HCV infection. We established HCV transgenic mouse model using Cre/loxP switching system. We put neomycin resistance gene as a stuffer flanked by loxP sequence at both 5' and 3' end between CAG promoter and core to NS2, HCV cDNA CN2. Spleens were harvested from CN2 transgenic mice. In 2 lineages out of 8, cultured spleen cell and fibroblast highly expressed core, E1 and E2 proteins by western blot and immunostaining after infection with recombinant adeno virus (AxCANCre) which express cre DNA recombinase in infected cell. To induce HCV expression in vivo and in the liver, we injected AxCANCre to CN2 transgenic mouse from tail vein and HCV protein expression was confirmed in its liver tissue. With the expression of HCV structural protein, acute liver injury which was similar to human acute viral hepatitis was occurred. It was accompanied with apoptotic liver cell death. Serum core protein was detected in transgenic mice 7 days after AxCANCre injection with evident serum ALT elevations, subsequently, anti-core antibody response was detected at 14 days after infection. Furthermore, CD4 and CD8 positive cell depletion assay normalized the serum ALT elevations of mice and pathological changes in the liver. These results suggest that HCV proteins are not direct cytopathic and the host immune response has a pivotal roles in HCV infection. This transgenic mouse model system allows us to analyze the functions of viral products and host immune system in HCV infection and hepatocellular carcinogenesis of HCV.
由于缺乏合适的培养体系和动物模型,阻碍了对病毒生活周期和HCV感染发病机制的深入研究。利用Cre/loxP转换系统建立了HCV转基因小鼠模型。我们将新霉素抗性基因作为填充物,在CAG启动子和核心之间的5'端和3'端两侧插入loxP序列,插入NS 2,HCV cDNA CN 2。从CN 2转基因小鼠中收获脾脏。用表达cre DNA重组酶的重组腺病毒(AxCANCre)感染培养的脾细胞和成纤维细胞后,Western blot和免疫组化染色显示,在8个谱系中有2个谱系的脾细胞和成纤维细胞高表达core、E1和E2蛋白。为了诱导HCV在体内和肝脏中的表达,我们从尾静脉注射AxCANCre给CN2转基因小鼠,并在其肝脏组织中证实了HCV蛋白表达。随着HCV结构蛋白的表达,出现了类似于人类急性病毒性肝炎的急性肝损伤。同时伴有肝细胞凋亡。转基因小鼠在AxCANCre注射后7天检测到血清核心蛋白,血清ALT明显升高,随后在感染后14天检测到抗核心抗体应答。此外,CD 4和CD 8阳性细胞耗竭试验使小鼠血清ALT升高和肝脏病理变化正常化。这些结果表明,HCV蛋白不是直接致细胞病变的,宿主免疫应答在HCV感染中起着关键作用。该转基因小鼠模型系统使我们能够分析病毒产物和宿主免疫系统在HCV感染和HCV肝细胞癌变中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
脇田隆字: "Cre/loxシステムを利用したHCVトランスジェニックマウスの確立" ウイルス. 48. 9-18 (1998)
Takaji Wakita:“利用 Cre/lox 系统建立 HCV 转基因小鼠”病毒。 48. 9-18 (1998)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Geissler M et al: "Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs." Vaccine. 16. 857-867 (1998)
Geissler M 等人:“使用嵌合结构进行基因免疫后,对 HCV 核心和 HBV 包膜蛋白的细胞和体液免疫反应存在差异。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Wakita T et al: "Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression." J.Med.Virol.57. 217-222 (1999)
Wakita T 等人:“反义 RNA 对丙型肝炎病毒 RNA 翻译和表达的抗病毒作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T Tanaka et al: "Acute hepatitis caused by sexual or household transmission of GBV-C J." Hepatology. 27. 1110-1112 (1997)
T Tanaka 等人:“GBV-C J 性传播或家庭传播引起的急性肝炎。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kondo S.et al: "Antisense telomerase treatment ; induction of two distinct pathways, apoptosis and differentiation." FASEB J.12. 801-811 (1998)
Kondo S.等人:“反义端粒酶治疗;诱导两种不同的途径:细胞凋亡和分化。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WAKITA Takaji其他文献
WAKITA Takaji的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WAKITA Takaji', 18)}}的其他基金
Analysis of hepatitis C virus sequence quasi species by NGS
NGS分析丙型肝炎病毒序列准种
- 批准号:
23659407 - 财政年份:2011
- 资助金额:
$ 6.66万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Cell culture system for genotype1b hepatitis C virus
基因1b型丙型肝炎病毒细胞培养系统
- 批准号:
21390235 - 财政年份:2009
- 资助金额:
$ 6.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of factors involved in viral replication efficiency and search for novel anti -virals using HCV culture systems.
使用 HCV 培养系统分析病毒复制效率相关因素并寻找新型抗病毒药物。
- 批准号:
18390225 - 财政年份:2006
- 资助金额:
$ 6.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of replication of Hepatitis C Virus using highly efficient replication system
使用高效复制系统分析丙型肝炎病毒的复制
- 批准号:
16590653 - 财政年份:2004
- 资助金额:
$ 6.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction and analysis of viral hepatocarcinogenesis model using HCV transgenic mouse model
HCV转基因小鼠病毒性肝癌模型的构建与分析
- 批准号:
14570531 - 财政年份:2002
- 资助金额:
$ 6.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction and analysis of viral hepatocarcinogenesis model using HCV transgenic mouse model
HCV转基因小鼠病毒性肝癌模型的构建与分析
- 批准号:
11670557 - 财政年份:1999
- 资助金额:
$ 6.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease
小胶质细胞免疫-氧甾醇25-羟基胆固醇在阿尔茨海默病P301S tau转基因小鼠模型中介导神经炎症和神经变性中的作用
- 批准号:
10645467 - 财政年份:2023
- 资助金额:
$ 6.66万 - 项目类别:
Characterization of a novel prostate cancer factor contactin 1 (CNTN1)-derived tumorigenesis through establishing a new transgenic mouse model for prostate cancer
通过建立新的前列腺癌转基因小鼠模型来表征新型前列腺癌因子接触蛋白 1 (CNTN1) 衍生的肿瘤发生
- 批准号:
488928 - 财政年份:2023
- 资助金额:
$ 6.66万 - 项目类别:
Operating Grants
To study the molecular oncogenesis of congenital Neurocutaneous melanocytosis in a preclinical transgenic mouse model
研究临床前转基因小鼠模型中先天性神经皮肤黑素细胞增多症的分子肿瘤发生
- 批准号:
10651336 - 财政年份:2023
- 资助金额:
$ 6.66万 - 项目类别:
An inducible and cell specific transgenic mouse model to study the HIV-1 antisense protein ASP
用于研究 HIV-1 反义蛋白 ASP 的诱导型和细胞特异性转基因小鼠模型
- 批准号:
10683237 - 财政年份:2022
- 资助金额:
$ 6.66万 - 项目类别:
An inducible and cell specific transgenic mouse model to study the HIV-1 antisense protein ASP
用于研究 HIV-1 反义蛋白 ASP 的诱导型和细胞特异性转基因小鼠模型
- 批准号:
10547001 - 财政年份:2022
- 资助金额:
$ 6.66万 - 项目类别:
Use of a novel transgenic mouse model to probe the molecular mechanisms of lipoprotein(a) pathogenicity in atherosclerosis
使用新型转基因小鼠模型探讨脂蛋白(a)致病性的分子机制
- 批准号:
463343 - 财政年份:2022
- 资助金额:
$ 6.66万 - 项目类别:
Operating Grants
Reduced allelic dosage of CLP1 attenuates cognitive dysfunction and pathological burden in transgenic mouse models of Alzheimer’s disease
减少 CLP1 等位基因剂量可减轻阿尔茨海默病转基因小鼠模型的认知功能障碍和病理负担
- 批准号:
10572250 - 财政年份:2022
- 资助金额:
$ 6.66万 - 项目类别:
Investigating Mechanisms of Neurodegeneration in Transgenic Mouse Models of Tauopathies
研究 Tau蛋白病转基因小鼠模型中神经变性的机制
- 批准号:
10372933 - 财政年份:2021
- 资助金额:
$ 6.66万 - 项目类别:
Use of a novel transgenic mouse model to probe the molecular mechanisms of lipoprotein(a) pathogenicity in atherosclerotic vascular disease
使用新型转基因小鼠模型探讨脂蛋白(a)在动脉粥样硬化性血管疾病中致病性的分子机制
- 批准号:
458698 - 财政年份:2021
- 资助金额:
$ 6.66万 - 项目类别:
Studentship Programs
Generation of a plasma cell-specific inducible Cre transgenic mouse
浆细胞特异性诱导型 Cre 转基因小鼠的产生
- 批准号:
10375383 - 财政年份:2021
- 资助金额:
$ 6.66万 - 项目类别: